Improved adherence with non-PO medications: What are the data? - Susan Swindells, MBBS

Workshop on Healthy Living with HIV 2020

Drug resistance among youth with confirmed virologic failure on first line and response to second line ART in Harare, Zimbabwe.

International Workshop on HIV & Pediatrics 2019

HIV Integrase Inhibitors: A new mechanism of action | Charles Boucher, MD, PhD

Argentina HIV Clinical Forum 2018

Perspectives on the Use of Endogenous Bio-markers to Assess Transporter Mediated Drug-Drug Interations_DDIs - Vikram Arya, PhD, FCP

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020

Leveraging Reverse Transcriptase 2020 | Kuritzkes

Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020

Selected INSTI Highlights - CROI 2019 - Charles Boucher, MD, PhD

Asia-Pacific HIV Clinical Forum 2019

Designing Clinical Trials: Highlights & Tips - Andrew Hill, MD

Spanish HIV Clinical Forum 2016

Improved long acting drug delivery: What are the technologies - Andrew Owen, BSc, MSc, PhD, FSB

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019

The Non-adherent Patient A Good or Bad Candidate for CAB+RPV - Jose Castillo-Mancilla, MD

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

Nyaradzo Mavis Mgodi, MBChB, MMed - HIV Prevention – Role of Long Acting ARVs

African HIV Clinical Forum 2022